Vol 16, No 3 (2022)
Research paper
Published online: 2022-07-04

open access

Page views 3893
Article views/downloads 356
Get Citation

Connect on Social Media

Connect on Social Media

Coping mechanism and depression among Moslem patients treated with chemotherapy

Diyah Candra Anita1, Astriningrum Titipangesti1, Siti Fadhillah2, Wantonoro Wantonoro1
Palliat Med Pract 2022;16(3):142-149.

Abstract

Background: Chemotherapy patients commonly experience depression due to various physical complaints
suffered and the length of treatment therapy. Depression is closely related to morbidity and mortality.
Therefore, a good coping mechanism is needed to overcome it. This research aims to determine the
relationship between coping mechanisms and depression in chemotherapy patients.
Patients and methods: The design used was a quantitative correlation with a cross-sectional approach.
The respondents recruited were 52 patients using an accidental sampling technique. The research instrument
used was a questionnaire. Data were analysed using the contingency coefficient test.
Results: The results showed that most respondents had maladaptive coping mechanisms (53.2%), experienced
depression (59.6%), and there was no relationship between coping mechanisms and depression
(p = 0.213).
Conclusions: many factors can influence the depression level of cancer patients. These factors contribute
together, but some of them do not directly contribute to depression. One of the factors that do not
directly contribute is the coping mechanism.

Article available in PDF format

View PDF Download PDF file

References

  1. Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016; 7(1): 54–86.
  2. Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018; 31(12): 1770–1786.
  3. World Health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International agency for research on cancer. Geneva: World Health Organization, 2018 Sep 12.
  4. Depkes RI. Situasi penyakit kanker. 2016.
  5. Dewi M. Sebaran Kanker di Indonesia, Riset Kesehatan Dasar 2007. Indonesian Journal of Cancer. 2017; 11(1): 1.
  6. Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncol Lett. 2015; 9(4): 1509–1514.
  7. Niedzwiedz CL, Knifton L, Robb KA, et al. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019; 19(1): 943.
  8. Quattropani MC, Lenzo V, Filastro A. Predictive factors of anxiety and depression symptoms in patients with breast cancer undergoing chemotherapy. An explorative study based on metacognitions. J Psychopathology. 2017; 23(2): 67–73.
  9. Oancea C, Suciu C, Timar B, et al. The reciprocal relationship between coping mechanisms and lung cancer diagnosis: findings of a prospective study. Cancer Manag Res. 2018; 10: 33–40.
  10. Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017; 52: 58–70.
  11. Ng GC, Mohamed S, Sulaiman AH, et al. Anxiety and Depression in Cancer Patients: The Association with Religiosity and Religious Coping. J Relig Health. 2017; 56(2): 575–590.
  12. Gururajan A, Clarke G, Dinan TG, et al. Molecular biomarkers of depression. Neurosci Biobehav Rev. 2016; 64: 101–133.
  13. Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020; 25(7): 1487–1499.
  14. Lucette A, Ironson G, Pargament KI, et al. Spirituality and Religiousness are Associated With Fewer Depressive Symptoms in Individuals With Medical Conditions. Psychosomatics. 2016; 57(5): 505–513.
  15. Bombay EM. Hubungan Tingkat Depresi Dengan Mekanisme Koping Pasien Gagal Ginjal Kronik Yang Menjalani Hemodialisa Di RS PKU Muhammadiyah II Yogyakarta. 2 dan 8. 2016.
  16. Islami F, Fedewa SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States. Prev Med. 2019; 123: 316–323.
  17. Hinz A, Weis J, Brähler E, et al. Fatigue in cancer patients: comparison with the general population and prognostic factors. Support Care Cancer. 2020; 28(9): 4517–4526.
  18. Black JRM, McGranahan N. Genetic and non-genetic clonal diversity in cancer evolution. Nat Rev Cancer. 2021; 21(6): 379–392.
  19. Nguru IA. Analisis Gaya Hidup Penderita Kanker di RSUD Prof. Dr. WZ Johannes Kupang. CHMK Applied Scientific Journal. 2018; 1(2): 68–76.
  20. Kim HI, Lim H, Moon A. Sex Differences in Cancer: Epidemiology, Genetics and Therapy. Biomol Ther (Seoul). 2018; 26(4): 335–342.
  21. White A, Ironmonger L, Steele RJC, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018; 18(1): 906.
  22. Levi Z, Kark JD, Katz LH, et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study. Cancer. 2017; 123(20): 4022–4030.
  23. Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019; 69(2): 88–112.
  24. Utama Y. Analisis Kualitas Hidup Pasien Kanker Payudara. Jurnal 'Aisyiyah Medika. 2021; 6(1).
  25. Maria I, Sainal A, Nyorong M. Risiko gaya hidup terhadap kejadian kanker payudara pada wanita. Media Kesehatan Masyarakat Indonesia. 2017; 13(2): 157–166.
  26. Yoost BL, Crawford LR. Fundamentals of Nursing E–Book: Active Learning for Collaborative Practice. Elsevier Health Sciences, 2021 Dec 7.
  27. Wadsworth ME. Development of Maladaptive Coping: A Functional Adaptation to Chronic, Uncontrollable Stress. Child Dev Perspect. 2015; 9(2): 96–100.
  28. Nipp RD, El-Jawahri A, Fishbein JN, et al. The relationship between coping strategies, quality of life, and mood in patients with incurable cancer. Cancer. 2016; 122(13): 2110–2116.
  29. Howell D, Mayer DK, Fielding R, et al. Global Partners for Self-Management in Cancer. Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care. J Natl Cancer Inst. 2021; 113(5): 523–531.
  30. Zamanian H, Eftekhar-Ardebili H, Eftekhar-Ardebili M, et al. Religious Coping and Quality of Life in Women with Breast Cancer. Asian Pac J Cancer Prev. 2015; 16(17): 7721–7725.
  31. Bovero A, Leombruni P, Miniotti M, et al. Spirituality, quality of life, psychological adjustment in terminal cancer patients in hospice. Eur J Cancer Care (Engl). 2016; 25(6): 961–969.
  32. Al-Ruzzieh MA, Ayaad O. Work Stress, Coping Strategies, and Health-Related Quality of Life among Nurses at an International Specialized Cancer Center. Asian Pac J Cancer Prev. 2021; 22(9): 2995–3004.
  33. Mosher CE, Winger JG, Given BA, et al. Mental health outcomes during colorectal cancer survivorship: a review of the literature. Psychooncology. 2016; 25(11): 1261–1270.
  34. Wolanin A. Stress coping strategies in malignant diseases among women diagnosed with breast cancer and men diagnosed with prostate cancer. Palliat Med Pract. 2021; 15(4): 275–282.
  35. Costantini L, Pasquarella C, Odone A, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord. 2021; 279: 473–483.
  36. Nord CL. Predicting Response to Brain Stimulation in Depression: a Roadmap for Biomarker Discovery. Curr Behav Neurosci Rep. 2021; 8(1): 11–19.
  37. Leppert W. Palliative care – current challenges and opportunities. Palliat Med Pract. 2021; 15(4): 267–269.
  38. Deslouches B, Di YP. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget. 2017; 8(28): 46635–46651.



Palliative Medicine in Practice